US Appeals Court decision favors MSN Pharma in Novartis heart drug Entresto generic dispute Ruchika Sharma9 Dec 2024 10:00 AM ISTNovartis suffered a legal setback on Wednesday as the company failed to persuade a U.S. appeals court to halt MSN Pharmaceuticals' proposed generic of...
Novartis bolsters Neuroscience pipeline with in-licensing of PTC518 for Huntington's disease Ruchika Sharma3 Dec 2024 1:30 PM ISTBasel: Novartis has announced that it has entered into a global license and collaboration agreement with PTC Therapeutics for PTC518.PTC518 is an...
Novartis Kisqali gets European Commission nod in patients with HR+/HER2-early breast cancer at high risk of recurrence Ruchika Sharma28 Nov 2024 12:59 PM ISTBasel: Novartis has announced that the European Commission (EC) has approved Kisqali (ribociclib) in combination with an aromatase inhibitor (AI)...
Switzerland COMCO competition commission terminates Novartis probe without consequences Ruchika Sharma11 Oct 2024 12:30 PM ISTBerlin: Switzerland's COMCO competition commission said on Thursday that it has terminated a probe against Novartis into possibly using blocking...
USFDA approves Novartis Kisqali to reduce risk of recurrence in people with HR+/HER2- early breast cancer Ruchika Sharma18 Sept 2024 3:04 PM ISTBasel: Novartis has announced that the US Food and Drug Administration (FDA) has approved Kisqali (ribociclib) in combination with an aromatase...
Entresto: Novartis loses initial bid to block generic of blockbuster heart drug Ruchika Sharma14 Aug 2024 11:30 AM ISTLondon: Novartis, a leading pharmaceutical company, has failed in its attempt to convince a federal court to block MSN Pharmaceuticals, a generic...
Novartis bags USFDA accelerated approval for Fabhalta for reduction of proteinuria in primary IgA nephropathy Ruchika Sharma8 Aug 2024 11:30 AM ISTBasel: Novartis has announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Fabhalta (iptacopan), a...
Novartis strengthens radioligand therapy pipeline with agreement to buy Mariana Oncology Ruchika Sharma3 May 2024 12:58 PM ISTBasel: Novartis has announced that it has entered into an agreement to acquire Mariana Oncology, a preclinical-stage biotechnology company based...
Novartis radioligand therapy Lutathera gets USFDA nod for pediatric patients with gastroenteropancreatic neuroendocrine tumors Ruchika Sharma25 April 2024 12:14 PM ISTBasel: Novartis has announced that the U.S. Food and Drug Administration (FDA) has approved Lutathera (USAN: lutetium Lu 177 dotatate / INN:...
Arvinas, Novartis collaborate for development, commercialization of ARV-766 for prostate cancer Ruchika Sharma14 April 2024 10:00 AM ISTNew Haven: Arvinas, Inc., a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, has...
Novartis tender offer for MorphoSys AG commences Ruchika Sharma12 April 2024 3:30 PM ISTBasel: Novartis has published the offer document for the voluntary public takeover offer by its wholly owned subsidiary Novartis BidCo AG for all...
Novartis Fabhalta gets positive CHMP opinion as first oral monotherapy for adult patients with paroxysmal nocturnal hemoglobinuria Ruchika Sharma24 March 2024 2:30 PM ISTBasel: Novartis has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a...
